메뉴 건너뛰기




Volumn 19, Issue 2, 2013, Pages 283-290

Impact of Pretransplantation Risk Factors on Post Transplantation Outcome of Patients with Acute Myeloid Leukemia in Remission after Haploidentical Hematopoietic Stem Cell Transplantation

Author keywords

Acute myeloid leukemia; Cytogenetics; Response; Risk; Transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

EID: 84872601267     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.10.002     Document Type: Article
Times cited : (28)

References (34)
  • 1
    • 0037114753 scopus 로고    scopus 로고
    • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
    • Byrd J.C., Mrózek K., Dodge R.K., et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002, 100:4325-4336.
    • (2002) Blood , vol.100 , pp. 4325-4336
    • Byrd, J.C.1    Mrózek, K.2    Dodge, R.K.3
  • 2
    • 32944473733 scopus 로고    scopus 로고
    • Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience
    • Jourdan E., Boiron J.-M., Dastugue N., et al. Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience. J Clin Oncol 2005, 23:7676-7684.
    • (2005) J Clin Oncol , vol.23 , pp. 7676-7684
    • Jourdan, E.1    Boiron, J.-M.2    Dastugue, N.3
  • 3
    • 67049164836 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials
    • Koreth J., Schlenk R., Kopecky K.J., et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009, 301:2349-2361.
    • (2009) JAMA , vol.301 , pp. 2349-2361
    • Koreth, J.1    Schlenk, R.2    Kopecky, K.J.3
  • 4
    • 0033845937 scopus 로고    scopus 로고
    • Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience
    • Sierra J., Storer B., Hansen J.A., et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant 2000, 26:397-404.
    • (2000) Bone Marrow Transplant , vol.26 , pp. 397-404
    • Sierra, J.1    Storer, B.2    Hansen, J.A.3
  • 5
    • 20644470338 scopus 로고    scopus 로고
    • Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse
    • Aversa F., Terenzi A., Tabilio A., et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005, 23:3447-3454.
    • (2005) J Clin Oncol , vol.23 , pp. 3447-3454
    • Aversa, F.1    Terenzi, A.2    Tabilio, A.3
  • 6
    • 0030734536 scopus 로고    scopus 로고
    • An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation
    • Horowitz M.M., Rowlings P.A. An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol 1997, 4:395-400.
    • (1997) Curr Opin Hematol , vol.4 , pp. 395-400
    • Horowitz, M.M.1    Rowlings, P.A.2
  • 7
    • 84864879416 scopus 로고    scopus 로고
    • Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis
    • Wang Y., Liu D.H., Xu L.P., et al. Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis. Bone Marrow Transplant 2011, 10.1038/bmt.2011.213.
    • (2011) Bone Marrow Transplant
    • Wang, Y.1    Liu, D.H.2    Xu, L.P.3
  • 8
    • 0030762673 scopus 로고    scopus 로고
    • Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    • Ferrant A., Labopin M., Frassoni F., et al. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood 1997, 90:2931-2938.
    • (1997) Blood , vol.90 , pp. 2931-2938
    • Ferrant, A.1    Labopin, M.2    Frassoni, F.3
  • 9
    • 34347391058 scopus 로고    scopus 로고
    • Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
    • Tallman M.S., Dewald G.W., Gandham S., et al. Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood 2007, 110:409-417.
    • (2007) Blood , vol.110 , pp. 409-417
    • Tallman, M.S.1    Dewald, G.W.2    Gandham, S.3
  • 10
    • 0008381951 scopus 로고    scopus 로고
    • A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRCAML 10 trial
    • Wheatley K., Burnett A.K., Goldstone A.H., et al. A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRCAML 10 trial. Br J Haematol 1999, 107:69-79.
    • (1999) Br J Haematol , vol.107 , pp. 69-79
    • Wheatley, K.1    Burnett, A.K.2    Goldstone, A.H.3
  • 11
    • 34247325560 scopus 로고    scopus 로고
    • Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
    • Cornelissen J.J., van Putten W.L., Verdonck L.F., et al. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?. Blood 2007, 109:3658-3666.
    • (2007) Blood , vol.109 , pp. 3658-3666
    • Cornelissen, J.J.1    van Putten, W.L.2    Verdonck, L.F.3
  • 12
    • 58249132219 scopus 로고    scopus 로고
    • Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation
    • Huang X.J., Liu D.H., Liu K.Y., et al. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transplant 2009, 15:257-265.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 257-265
    • Huang, X.J.1    Liu, D.H.2    Liu, K.Y.3
  • 13
    • 84872603504 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network. Version 2. NCCN clinical practice guidelines in oncology acute myloid leukemia. Available at:
    • National Comprehensive Cancer Network. Version 2. NCCN clinical practice guidelines in oncology acute myloid leukemia. Available at: , 2011. http://www.NCCN.org.
    • (2011)
  • 14
    • 0034672269 scopus 로고    scopus 로고
    • Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study
    • Slovak M.L., Kopecky K.J., Cassileth P.A., et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000, 96:4075-4083.
    • (2000) Blood , vol.96 , pp. 4075-4083
    • Slovak, M.L.1    Kopecky, K.J.2    Cassileth, P.A.3
  • 15
    • 84857365039 scopus 로고    scopus 로고
    • Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation
    • Zhao X.S., Liu Y.R., Zhu H.H., et al. Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation. Ann Hematol 2012, 91:183-192.
    • (2012) Ann Hematol , vol.91 , pp. 183-192
    • Zhao, X.S.1    Liu, Y.R.2    Zhu, H.H.3
  • 16
    • 84859464436 scopus 로고    scopus 로고
    • Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT
    • Zhao X.S., Jin S., Zhu H.H., et al. Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT. Bone Marrow Transplant 2012, 47:499-507.
    • (2012) Bone Marrow Transplant , vol.47 , pp. 499-507
    • Zhao, X.S.1    Jin, S.2    Zhu, H.H.3
  • 17
    • 84859572115 scopus 로고    scopus 로고
    • Risk stratification-directed donor lymphocyte infusion could reduce relapse of patients with standard-risk acute leukemia after allogeneic hematopoietic stem cell transplantation
    • Yan C.H., Liu D.H., Liu K.Y., et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of patients with standard-risk acute leukemia after allogeneic hematopoietic stem cell transplantation. Blood 2012, 119:3256-3262.
    • (2012) Blood , vol.119 , pp. 3256-3262
    • Yan, C.H.1    Liu, D.H.2    Liu, K.Y.3
  • 18
    • 70349137580 scopus 로고    scopus 로고
    • Administration of short-term immunosuppressive agents after GPBPCI reduces the incidence of GPBPCI associated acute GVHD without influencing the GVL effect
    • Huang X.J., Wang Y., Liu D.H., et al. Administration of short-term immunosuppressive agents after GPBPCI reduces the incidence of GPBPCI associated acute GVHD without influencing the GVL effect. Bone Marrow Transplant 2009, 44:309-316.
    • (2009) Bone Marrow Transplant , vol.44 , pp. 309-316
    • Huang, X.J.1    Wang, Y.2    Liu, D.H.3
  • 19
    • 34247602156 scopus 로고    scopus 로고
    • Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haplo-identical T-cell-replete hematopoietic stem cell transplantation
    • Huang X.J., Liu D.H., Liu K.Y., et al. Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haplo-identical T-cell-replete hematopoietic stem cell transplantation. Haematologica 2007, 92:414-417.
    • (2007) Haematologica , vol.92 , pp. 414-417
    • Huang, X.J.1    Liu, D.H.2    Liu, K.Y.3
  • 20
    • 0032188805 scopus 로고    scopus 로고
    • The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties
    • Grimwade D., Walker H., Oliver F., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998, 92:2322-2333.
    • (1998) Blood , vol.92 , pp. 2322-2333
    • Grimwade, D.1    Walker, H.2    Oliver, F.3
  • 22
    • 77956481553 scopus 로고    scopus 로고
    • Regression modeling of competing risk using R: an in depth guide for clinicians
    • Scrucca L., Santucci A., Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010, 45:1388-1395.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 1388-1395
    • Scrucca, L.1    Santucci, A.2    Aversa, F.3
  • 23
    • 54349092877 scopus 로고    scopus 로고
    • Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype
    • Breems D.A., Van Putten W.L., De Greef G.E., et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008, 26:4791-4797.
    • (2008) J Clin Oncol , vol.26 , pp. 4791-4797
    • Breems, D.A.1    Van Putten, W.L.2    De Greef, G.E.3
  • 24
    • 84855584157 scopus 로고    scopus 로고
    • Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study
    • Armand P., Kim H.T., Zhang M.J., et al. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant 2012, 18:280-288.
    • (2012) Biol Blood Marrow Transplant , vol.18 , pp. 280-288
    • Armand, P.1    Kim, H.T.2    Zhang, M.J.3
  • 25
    • 0042527742 scopus 로고    scopus 로고
    • Risk adapted post-remission therapy in acute myeloid leukemia: results of the German Multicenter AML HD93 treatment trial
    • Schlenk R.F., Benner A., Hartmann F., et al. Risk adapted post-remission therapy in acute myeloid leukemia: results of the German Multicenter AML HD93 treatment trial. Leukemia 2003, 17:1521-1528.
    • (2003) Leukemia , vol.17 , pp. 1521-1528
    • Schlenk, R.F.1    Benner, A.2    Hartmann, F.3
  • 26
    • 0041737626 scopus 로고    scopus 로고
    • Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): An intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial
    • Suciu S., Mandelli F., de Witte T., et al. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): An intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. Blood 2003, 102:1232-1240.
    • (2003) Blood , vol.102 , pp. 1232-1240
    • Suciu, S.1    Mandelli, F.2    de Witte, T.3
  • 27
    • 33644985509 scopus 로고    scopus 로고
    • Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]
    • Perea G., Lasa A., Aventín A., et al. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]. Leukemia 2006, 20:87-94.
    • (2006) Leukemia , vol.20 , pp. 87-94
    • Perea, G.1    Lasa, A.2    Aventín, A.3
  • 28
    • 0037093053 scopus 로고    scopus 로고
    • A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup
    • Nguyen S., Leblanc T., Fenaux P., et al. A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup. Blood 2002, 99:3517-3523.
    • (2002) Blood , vol.99 , pp. 3517-3523
    • Nguyen, S.1    Leblanc, T.2    Fenaux, P.3
  • 29
    • 0022621521 scopus 로고
    • Risk factors for cytomegalovirus infection after human marrow transplantation
    • Meyers J.D., Flournoy N., Thomas E.D. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986, 153:478-488.
    • (1986) J Infect Dis , vol.153 , pp. 478-488
    • Meyers, J.D.1    Flournoy, N.2    Thomas, E.D.3
  • 30
    • 84857779288 scopus 로고    scopus 로고
    • Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study
    • Kanda J., Hishizawa M., Utsunomiya A., et al. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood 2012, 119:2141-2148.
    • (2012) Blood , vol.119 , pp. 2141-2148
    • Kanda, J.1    Hishizawa, M.2    Utsunomiya, A.3
  • 31
    • 0034554848 scopus 로고    scopus 로고
    • Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia
    • Venditti A., Buccisano F., Del Poeta G. Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. Blood 2000, 96:3948-3952.
    • (2000) Blood , vol.96 , pp. 3948-3952
    • Venditti, A.1    Buccisano, F.2    Del Poeta, G.3
  • 32
    • 10744231089 scopus 로고    scopus 로고
    • Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
    • Venditti A., Maurillo L., Buccisano F., et al. Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation. Leukemia 2003, 17:2178-2182.
    • (2003) Leukemia , vol.17 , pp. 2178-2182
    • Venditti, A.1    Maurillo, L.2    Buccisano, F.3
  • 33
    • 23944440464 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
    • Sorror M.L., Maris M.B., Storb R., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
    • (2005) Blood , vol.106 , pp. 2912-2919
    • Sorror, M.L.1    Maris, M.B.2    Storb, R.3
  • 34
    • 72949123602 scopus 로고    scopus 로고
    • Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies
    • Chang Y.J., Zhao X.Y., Huo M.R., et al. Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies. Medicine (Baltimore) 2009, 88:322-330.
    • (2009) Medicine (Baltimore) , vol.88 , pp. 322-330
    • Chang, Y.J.1    Zhao, X.Y.2    Huo, M.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.